(CYTK) Cytokinetics - Performance -32.3% in 12m
Compare CYTK with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
39.25%
#13 in Group
Rel. Strength
19.14%
#6451 in Universe
Total Return 12m
-32.27%
#83 in Group
Total Return 5y
182.93%
#14 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -0.42
26th Percentile in Group
FCF Yield -9.70%
(?) Percentile in Group
12m Total Return: CYTK (-32.3%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: CYTK vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CYTK
Total Return (including Dividends) | CYTK | XBI | S&P 500 |
---|---|---|---|
1 Month | 14.45% | 5.55% | -0.45% |
3 Months | -11.44% | -9.75% | -6.29% |
12 Months | -32.27% | -5.39% | 13.04% |
5 Years | 182.93% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | CYTK | XBI | S&P 500 |
1 Month | 60.1% | 70% | 47.5% |
3 Months | -71.6% | -88.1% | -87.3% |
12 Months | -82.9% | -44.4% | 54.3% |
5 Years | 77.8% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #72 | 8.43% | 15.0% |
3 Month | #78 | -1.87% | -5.49% |
12 Month | #83 | -28.4% | -40.1% |
5 Years | #12 | 226% | 33.6% |
FAQs
Does CYTK Cytokinetics outperforms the market?
No,
over the last 12 months CYTK made -32.27%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months CYTK made -11.44%, while XBI made -9.75%.
Over the last 3 months CYTK made -11.44%, while XBI made -9.75%.
Performance Comparison CYTK vs Indeces and Sectors
CYTK vs. Indices CYTK is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.27% | 14.9% | -15.6% | -45.3% |
US NASDAQ 100 | QQQ | 3.35% | 12.6% | -16.3% | -47.2% |
US Dow Jones Industrial 30 | DIA | 4.81% | 17.3% | -14.8% | -41.5% |
German DAX 40 | DAX | 4.63% | 14.7% | -33.7% | -57.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | 7.92% | 17.7% | -11.9% | -37.2% |
Hongkong Hang Seng | HSI | 4.67% | 16.0% | -16.1% | -45.2% |
India NIFTY 50 | INDA | 6.79% | 9.57% | -15.5% | -35.2% |
Brasil Bovespa | EWZ | 5.90% | 11.6% | -21.3% | -25.5% |
CYTK vs. Sectors CYTK is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.12% | 15.1% | -21.6% | -55.7% |
Consumer Discretionary | XLY | 4.24% | 15.0% | -16.8% | -46.9% |
Consumer Staples | XLP | 6.33% | 15.3% | -19.7% | -43.2% |
Energy | XLE | 8.53% | 28.5% | -10.5% | -23.0% |
Financial | XLF | 5.38% | 16.5% | -22.5% | -54.9% |
Health Care | XLV | 6.97% | 19.1% | -10.4% | -31.0% |
Industrial | XLI | 3.95% | 14.2% | -16.6% | -43.0% |
Materials | XLB | 6.08% | 17.7% | -7.75% | -27.8% |
Real Estate | XLRE | 4.38% | 15.6% | -15.8% | -50.6% |
Technology | XLK | 2.71% | 12.0% | -12.6% | -42.7% |
Utilities | XLU | 5.55% | 14.4% | -20.0% | -53.1% |
Aerospace & Defense | XAR | 3.24% | 7.47% | -29.5% | -59.8% |
Biotech | XBI | 4.43% | 8.90% | -0.28% | -26.9% |
Homebuilder | XHB | 5.54% | 16.5% | -0.63% | -26.1% |
Retail | XRT | 5.51% | 15.6% | -9.63% | -30.8% |